Office of Criminal Investigations/Center Coordination (1)

Description: Enhance the coordination, communication, and strategy in alignment of the Office of Criminal Investigations (OCI) and other FDA components by implementing the findings and recommendations of the OCI/Center coordination and Alignment Review Committee.

Accomplishment: In completion of the key project, the Office of the Counselor to the Commissioner implemented the findings and recommendations of the Office of Criminal Investigations/Center coordination and Alignment Review Committee. Outcomes of this initiative are as follows:

Improved procedures for the standardization and coordination of information sharing between OCI and other agency components;

Established mechanisms to ensure that senior leaders share information and coordinate strategic priorities to align criminal enforcement and regulatory activities;

Increased appropriate use of misdemeanor prosecutions through greater clarity on the criteria for approving such cases to hold corporate officials accountable; encourage preventive actions; and achieve greater deterrence;

Enhanced procedures to support development of debarment and disqualification actions, and clarify the circumstances under which such administrative actions may proceed concurrently with pending criminal investigations and prosecutions; and

Established enhanced procedures to coordinate agency response to cargo theft of FDA regulated products, such as pharmaceuticals and infant formula, to ensure that FDA’s regulatory response to cargo thefts is consistent and fully effective.

Related Links

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.